title: Telemonitoring: use in the management of hypertension.
abstract: Hypertension is a major modifiable risk factor for cardiovascular, retinal, and kidney disease. In the past decade, attainment rates of treatment targets for blood pressure control in the UK and US have increased; however, <11% of adult men and women have achieved adequate blood pressure control. Technological advances in blood pressure measurement and data transmission may improve the capture of information but also alter the relationship between the patient and the provider of care. Telemonitoring systems can be used to manage patients with hypertension, and have the ability to enable best-practice decisions more consistently. The improvement in choice for patients as to where and who manages their hypertension, as well as better adherence to treatment, are potential benefits. An evidence base is growing that shows that telemonitoring can be more effective than usual care in improving attainment rates of goal blood pressure in the short-to-medium term. In addition, studies are in progress to assess whether this technology could be a part of the solution to address the health care needs of an aging population and improve access for those suffering health inequalities. The variation in methods and systems used in these studies make generalizability to the general hypertension population difficult. Concerns over the reliability of technology, impact on patient quality of life, longer-term utility and cost-benefit analyses all need to be investigated further if wider adoption is to occur.
authors.affiliation: Thomas Addison Unit, St George's Hospital, London, UK.
authors.forename: Darshi
authors.initials: D
authors.lastname: Sivakumaran
authors.affiliation: Thomas Addison Unit, St George's Hospital, London, UK ; Clinical Sciences, St George's University of London, London, UK.
authors.forename: Kenneth Anthony
authors.initials: KA
authors.lastname: Earle
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination; D019033:Delivery of Health Care, Integrated; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D055118:Medication Adherence; D010348:Patient Care Team; D011237:Predictive Value of Tests; D017216:Telemedicine; D013686:Telemetry; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents
keywords: health surveillance; telehealth; virtual-led clinic
references.citation: Proc R Soc Med. 1977 Nov;70(11):793-9
references.pmid: 341169
references.citation: Circulation. 2012 Jan 3;125(1):e2-e220
references.pmid: 22179539
references.citation: N Engl J Med. 2004 Sep 23;351(13):1296-305
references.pmid: 15385656
references.citation: J Telemed Telecare. 2009;15(3):125-8
references.pmid: 19364893
references.citation: N Engl J Med. 2001 Sep 20;345(12):870-8
references.pmid: 11565519
references.citation: Cochrane Database Syst Rev. 2000;(3):CD000336
references.pmid: 10908471
references.citation: Diabetes Care. 2013 Oct;36(10):3287-96
references.pmid: 23690530
references.citation: Hypertension. 1998 Apr;31(4):1014-20
references.pmid: 9535429
references.citation: Kidney Int. 2007 Jul;72(1):92-9
references.pmid: 17440495
references.citation: JAMA. 2008 Jun 25;299(24):2857-67
references.pmid: 18577730
references.citation: Trials. 2013 Jan 23;14:22
references.pmid: 23343138
references.citation: JAMA. 2010 Jan 20;303(3):235-41
references.pmid: 20071471
references.citation: BMJ. 2011 Aug 25;343:d4891
references.pmid: 21868454
references.citation: Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005182
references.pmid: 16625627
references.citation: Nephrol Dial Transplant. 2001;16 Suppl 1:63-6
references.pmid: 11369824
references.citation: Hypertension. 2012 Jul;60(1):51-7
references.pmid: 22615116
references.citation: Am J Hypertens. 2009 Mar;22(3):263-6
references.pmid: 19057514
references.citation: Diabetologia. 2001 Dec;44(12):2203-9
references.pmid: 11793022
references.citation: J Hypertens. 2013 Mar;31(3):455-67; discussion 467-8
references.pmid: 23299557
references.citation: BMJ. 2008 May 17;336(7653):1121-3
references.pmid: 18480116
references.citation: Health Educ Q. 1988 Summer;15(2):175-83
references.pmid: 3378902
references.citation: Cardiol Clin. 2002 May;20(2):207-23
references.pmid: 12119797
references.citation: Am J Hypertens. 2011 Sep;24(9):989-98
references.pmid: 21654858
references.citation: J Telemed Telecare. 2009;15(6):281-5
references.pmid: 19720764
references.citation: BMJ. 2013 Feb 26;346:f653
references.pmid: 23444424
references.citation: Diabetes Technol Ther. 2010 Jul;12(7):575-9
references.pmid: 20597833
references.citation: BMC Med Inform Decis Mak. 2006 Apr 05;6:20
references.pmid: 16597341
references.citation: Trials. 2011 Oct 20;12:231
references.pmid: 22014122
references.citation: Hypertension. 2011 Oct;58(4):552-8
references.pmid: 21844490
references.citation: Br Med Bull. 1994 Apr;50(2):272-98
references.pmid: 8205459
references.citation: Lancet. 2010 Jul 17;376(9736):163-72
references.pmid: 20619448
references.citation: J Am Med Inform Assoc. 2009 Jul-Aug;16(4):446-56
references.pmid: 19390093